The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 24, 2024
Filed:
May. 20, 2022
Bio-rad Laboratories, Inc., Hercules, CA (US);
Benjamin J. Hindson, Livermore, CA (US);
Serge Saxonov, Oakland, CA (US);
Phillip Belgrader, Severna Park, MD (US);
Kevin D. Ness, Pleasanton, CA (US);
Michael Y. Lucero, San Francisco, CA (US);
Billy W. Colston, Jr., San Ramon, CA (US);
Shawn Paul Hodges, Newark, CA (US);
Nicholas J. Heredia, Mountain House, CA (US);
Jeffrey Clark Mellen, San Francisco, CA (US);
Camille Bodley Troup, Livermore, CA (US);
Paul Wyatt, Foster City, CA (US);
Bio-Rad Laboratories, Inc., Hercules, CA (US);
Abstract
The present disclosure provides methods and compositions for detecting polynucleotides in a sample and for quantifying polynucleotide load in a sample. The polynucleotides can be associated with a disease, disorder, or condition. In some applications, methylated DNA is quantified, e.g., in order to determine the load of polynucleotides in a sample. The present disclosure also provides methods and compositions for determining the load of fetal polynucleotides in a biological sample, e.g., the load of fetal polynucleotides (e.g., DNA, RNA) in maternal plasma. The present disclosure provides methods and compositions for detecting cellular processes such as cellular viability, growth rates, and infection rates. This disclosure also provides compositions and methods for detecting differences in copy number of a target polynucleotide. In some embodiments, the methods and compositions provided herein are useful for diagnosis of fetal genetic abnormalities, when the starting sample is maternal tissue (e.g., blood, plasma). The methods and materials described apply techniques for allowing detection of small, but statistically significant, differences in polynucleotide copy number.